1. Home
  2. RRC vs BIO Comparison

RRC vs BIO Comparison

Compare RRC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$36.34

Market Cap

8.2B

Sector

Energy

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$296.65

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
BIO
Founded
1976
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RRC
BIO
Price
$36.34
$296.65
Analyst Decision
Hold
Strong Buy
Analyst Count
17
4
Target Price
$41.29
$358.50
AVG Volume (30 Days)
2.9M
199.1K
Earning Date
02-24-2026
02-12-2026
Dividend Yield
0.99%
N/A
EPS Growth
19.84
N/A
EPS
2.38
N/A
Revenue
$2,891,506,000.00
$2,557,500,000.00
Revenue This Year
$27.23
$1.62
Revenue Next Year
$11.85
$2.26
P/E Ratio
$15.29
N/A
Revenue Growth
24.57
N/A
52 Week Low
$30.32
$211.43
52 Week High
$43.50
$373.69

Technical Indicators

Market Signals
Indicator
RRC
BIO
Relative Strength Index (RSI) 58.07 34.91
Support Level $35.70 $306.52
Resistance Level $37.11 $316.63
Average True Range (ATR) 1.12 10.12
MACD 0.37 -2.04
Stochastic Oscillator 80.09 7.24

Price Performance

Historical Comparison
RRC
BIO

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.2 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: